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To the Editor: We were interested by the recent article by Penno et al, who reported that the majority (17/29) of their participants with stage ≥3 chronic kidney disease (CKD) and type 1 diabetes had the non-albuminuric phenotype (Alb − ; albuminuria <3.4 mg/mmol) [1] ; this is an unexpectedly high proportion. As reported by the authors, these participants had higher Modification of Diet in Renal Disease (MDRD) Study equation-estimated GFR (eGFR) (52 ± 7 ml min , and the history of cardiovascular events were similarly prevalent in the 19 individuals in the Alb + group (n = 5, 26%) and the 16 individuals in the Alb − group (n = 4, 25%). We speculate whether the 10 out of 29 participants with stage ≥3 CKD in Penno et al's study who also had previous cardiovascular events (as reported in Table 1 in their article) were also similarly distributed between the Alb − and Alb + group. Further longitudinal studies will be required to determine whether Alb − CKD seriously progresses to cardiovascular events, dialysis or death in type 1 diabetes.
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